GgoogleJP first seen 7 h ago, last 7 h ago, peak #1

Shionogi acquires US biotech IntraBio

Original: アクーゴ

Shionogi Pharmaceutical has announced the acquisition of US-based IntraBio, gaining access to treatments for rare neurological diseases. The deal gives the Japanese drugmaker a foothold in the niche but high-value rare disease market, and the move is drawing attention in Japan's pharmaceutical industry as Shionogi expands beyond its infectious disease focus.

Why now: Shionogi's acquisition of IntraBio was just announced, making it trending news in Japan.

Shionogi & Co.IntraBioJapanUnited States

Open on google →

Evidence

• 塩野義製薬、米国のバイオ医薬品企業を買収へ 3155億円で · 朝日新聞
• 塩野義製薬、米IntraBioを買収 希少神経疾患の治療薬を獲得 · 47NEWS

API: https://socialmediatrends-api.osmike.com/v1/trends/1467567